Zobrazeno 1 - 10
of 576
pro vyhledávání: '"MDR-TB treatment regimens"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Taoping Weng, Feng Sun, Yang Li, Jiazhen Chen, Xinchang Chen, Rong Li, Shijia Ge, Yanlin Zhao, Wenhong Zhang
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Multidrug-resistant tuberculosis (MDR-TB) are unsatisfied to treat, pressing more effective and innovative treatment regimens. New efficient regimens for MDR-TB have obtained high treatment success rates. However, those regimens w
Externí odkaz:
https://doaj.org/article/5ce14a0adb924653908633ac099d1775
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Modongo, Chawangwa1,2,3 (AUTHOR) ntungwana@yahoo.co.uk, Sobota, Rafal S.4 (AUTHOR) rafal4484@gmail.com, Kesenogile, Boikobo3,5 (AUTHOR) kesenogile@yahoo.co.uk, Ncube, Ronald6 (AUTHOR) rtncube@gmail.com, Sirugo, Giorgio7 (AUTHOR) gsirugo@gmail.com, Williams, Scott M.4 (AUTHOR) Scott.Williams@dartmouth.edu, Zetola, Nicola M.1,2,3 (AUTHOR) nzetola@gmail.com
Publikováno v:
BMC Infectious Diseases. 2014, Vol. 14 Issue 1, p542-20. 20p. 4 Charts.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yanlin Zhao, Rong Li, Taoping Weng, Shijia Ge, Yang Li, Wenhong Zhang, Jiazhen Chen, Xinchang Chen, Feng Sun
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
Background Multidrug-resistant tuberculosis (MDR-TB) are unsatisfied to treat, pressing more effective and innovative treatment regimens. New efficient regimens for MDR-TB have obtained high treatment success rates. However, those regimens without dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9310bfd3f8e1e08dd27825c0ab622ce8
https://doi.org/10.1186/s12879-021-05870-w
https://doi.org/10.1186/s12879-021-05870-w
Autor:
Taoping Weng, Sun, Feng, Li, Yang, Jiazhen Chen, Xinchang Chen, Li, Rong, Shijia Ge, Yanlin Zhao, Wenhong Zhang
Additional file 1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36079256c54be43a3da29b1023a79bec
Autor:
Yadong Liu, Daquan Cao, Xinghua Cao, Vipin Jain, Chanchal Chawla, Malik Shahzad Shabbir, Carlos Samuel Ramos-Meza
Publikováno v:
Energy & Environment. :0958305X2210794
This study examines socioeconomic and spatial factors and its influences on the outcomes of environmental-health through “multi-drug resistance tuberculosis” (MDR-TB) treatment regimes in China. For this purpose, a survival analysis is conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93a7ba43aea4a545361b105ba6e2f573
https://doi.org/10.1177/0958305x221079425
https://doi.org/10.1177/0958305x221079425
Autor:
Rusen ID; International Union Against Tuberculosis and Lung Disease Paris, France, Division of Research and Development, Vital Strategies New York, NY, USA, Dalla Lana School of Public Health, University of Toronto Toronto, ON, Canada., Chiang CY; International Union Against Tuberculosis and Lung Disease Paris, France, Division of Pulmonary Medicine, Department of Internal Medicine Wan Fang Hospital, Taipei Medical University, Division of Pulmonary Medicine, Department of Internal Medicine School of Medicine, College of Medicine Taipei Medical University, Taipei, Taiwan cychiang@theunion.org , Email: irusen@theunion.org.
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2018 Jan 01; Vol. 22 (1), pp. 1-2.
Autor:
Patrick P. J. Phillips
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 20:4-7
In contrast to the treatment of drug-susceptible tuberculosis (TB), the evidence base underpinning global guidelines for the treatment of multidrug-resistant (MDR) TB is very poor. This, combined with the lack of experience from previous trials and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80d39584cd050605ccdbcfe9a53b7a1d
https://doi.org/10.5588/ijtld.16.0061
https://doi.org/10.5588/ijtld.16.0061